Communicable Diseases  >>  Hutruo (bermekimab IV)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hutruo (bermekimab IV) / J&J
NCT02643654 / 2015-002321-20: MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB

Completed
2
20
Europe
MABp1, Placebo
Evangelos J. Giamarellos-Bourboulis, M.D., Hellenic Institute for the Study of Sepsis
Hidradenitis Suppurativa
10/16
02/17

Download Options